Cargando…
iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy
BACKGROUND: Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be the key to avoiding damage from this condition. METHODS: Proteomic iTRAQ technology was first used to identify differenti...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668123/ https://www.ncbi.nlm.nih.gov/pubmed/31384238 http://dx.doi.org/10.1186/s12014-019-9253-1 |